Research ExplorerPublicationsMarketing Status and Perceived Efficacy of Drugs for Support...

Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders A Survey among European Federation of Addiction Societies in Europe

Standard

Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders A Survey among European Federation of Addiction Societies in Europe. / Bramness, Jørgen G; Mann, Karl; Wurst, Friedrich M.

In: EUR ADDICT RES, Vol. 22, No. 6, 2016, p. 318-321.

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Harvard

Bramness, JG, Mann, K & Wurst, FM 2016, 'Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders A Survey among European Federation of Addiction Societies in Europe', EUR ADDICT RES, vol. 22, no. 6, pp. 318-321. https://doi.org/10.1159/000447965

APA

Bramness, J. G., Mann, K., & Wurst, F. M. (2016). Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders A Survey among European Federation of Addiction Societies in Europe. EUR ADDICT RES, 22(6), 318-321. https://doi.org/10.1159/000447965

Vancouver

Bramness JG, Mann K, Wurst FM. Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders A Survey among European Federation of Addiction Societies in Europe. EUR ADDICT RES. 2016;22(6):318-321. https://doi.org/10.1159/000447965

Bibtex

@article{ae5931bc3d4b43c49ba75e5869ac4d62,
title = "Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders A Survey among European Federation of Addiction Societies in Europe",
abstract = "BACKGROUND: Acamprosate, disulfiram (DIS), naltrexone and nalmefene can be used in treating alcohol use disorders. The drugs are, however, underutilized.METHODS: In this survey of marketing status and perceived efficacy, member societies of the European federation for addiction societies were asked to report on the status of these drugs in their country. Results were obtained from 20 European countries showing that the drugs were registered in most countries.RESULTS AND CONCLUSION: The drugs were mentioned in guidelines in approximately half and were partially or fully reimbursed in half to two-thirds countries. DIS was perceived as the most efficacious drug. These results are discussed.",
author = "Bramness, {J{\o}rgen G} and Karl Mann and Wurst, {Friedrich M}",
note = "Short Communication",
year = "2016",
doi = "10.1159/000447965",
language = "English",
volume = "22",
pages = "318--321",
journal = "EUR ADDICT RES",
issn = "1022-6877",
publisher = "S. Karger AG",
number = "6",

}

RIS

TY - JOUR

T1 - Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders A Survey among European Federation of Addiction Societies in Europe

AU - Bramness, Jørgen G

AU - Mann, Karl

AU - Wurst, Friedrich M

N1 - Short Communication

PY - 2016

Y1 - 2016

N2 - BACKGROUND: Acamprosate, disulfiram (DIS), naltrexone and nalmefene can be used in treating alcohol use disorders. The drugs are, however, underutilized.METHODS: In this survey of marketing status and perceived efficacy, member societies of the European federation for addiction societies were asked to report on the status of these drugs in their country. Results were obtained from 20 European countries showing that the drugs were registered in most countries.RESULTS AND CONCLUSION: The drugs were mentioned in guidelines in approximately half and were partially or fully reimbursed in half to two-thirds countries. DIS was perceived as the most efficacious drug. These results are discussed.

AB - BACKGROUND: Acamprosate, disulfiram (DIS), naltrexone and nalmefene can be used in treating alcohol use disorders. The drugs are, however, underutilized.METHODS: In this survey of marketing status and perceived efficacy, member societies of the European federation for addiction societies were asked to report on the status of these drugs in their country. Results were obtained from 20 European countries showing that the drugs were registered in most countries.RESULTS AND CONCLUSION: The drugs were mentioned in guidelines in approximately half and were partially or fully reimbursed in half to two-thirds countries. DIS was perceived as the most efficacious drug. These results are discussed.

U2 - 10.1159/000447965

DO - 10.1159/000447965

M3 - Other (editorial matter etc.)

C2 - 27438908

VL - 22

SP - 318

EP - 321

JO - EUR ADDICT RES

JF - EUR ADDICT RES

SN - 1022-6877

IS - 6

ER -